Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
Holding AVIR?
Track your performance easily

Atea Pharmaceuticals (AVIR) Technical Analysis

207 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Atea Pharmaceuticals’s (AVIR) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Atea Pharmaceuticals is a Sell.
Atea Pharmaceuticals’s (AVIR) 20-Day exponential moving average is 3.78, while Atea Pharmaceuticals’s (AVIR) share price is $3.905, making it a Buy.
Atea Pharmaceuticals’s (AVIR) 50-Day exponential moving average is 3.71, while Atea Pharmaceuticals’s (AVIR) share price is $3.905, making it a Buy.

Atea Pharmaceuticals (AVIR) Pivot Points

Sep 20, 2024, 02:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.52
3.67
3.84
3.99
4.17
4.32
4.50
Fibonacci
3.67
3.79
3.87
3.99
4.12
4.20
4.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atea Pharmaceuticals (AVIR) Moving Averages

Sep 20, 2024, 02:52 AM
Period
Simple
Exponential
MA5
3.89Buy
3.91Buy
MA10
3.77Buy
3.84Buy
MA20
3.79Buy
3.78Buy
MA50
3.69Buy
3.71Buy
MA100
3.67Buy
3.68Buy
MA200
3.69Buy
3.60Buy
Atea Pharmaceuticals’s (AVIR) 10-Day exponential moving average is 3.84, while Atea Pharmaceuticals’s (AVIR) share price is $3.905, making it a Buy.
Atea Pharmaceuticals’s (AVIR) 100-Day exponential moving average is 3.68, while Atea Pharmaceuticals’s (AVIR) share price is $3.905, making it a Buy.
Atea Pharmaceuticals’s (AVIR) stock price is $3.905 and Atea Pharmaceuticals’s (AVIR) 50-day simple moving average is 3.69, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.905 and Atea Pharmaceuticals’s (AVIR) 100-day simple moving average is 3.67, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.905 and Atea Pharmaceuticals’s (AVIR) 200-day simple moving average is 3.69, creating a Buy signal.

Atea Pharmaceuticals (AVIR) Technical Indicators

Sep 20, 2024, 02:52 AM
Name
Value
Implied Action
RSI (14)
62.38
Neutral
STOCH (9,6)
78.54
Neutral
STOCHRSI (14)
78.54
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
23.53
Neutral
Williams %R
-24.80
Buy
CCI (14)
139.83
Sell
ATR (14)
0.17
-
Ultimate Oscillator
57.82
Neutral
ROC
5.00
Buy
Atea Pharmaceuticals’s (AVIR) Relative Strength Index (RSI) is 62.38, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Trend Strength Indicator (ADX) is 23.53, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Commodity Channel Index (CCI) is 139.83, creating a Sell signal.
Atea Pharmaceuticals’s (AVIR) Price Rate of Change (ROC) is 5.00, creating a Buy signal.

FAQ

Is AVIR a Buy, Hold, or Sell?
Based on AVIR’s technical indicators, AVIR is a Strong Buy.
    What is AVIR’s RSI (14)?
    AVIR’s RSI (14) is 62.38, which suggests AVIR is a Neutral.
      What is AVIR’s MACD?
      AVIR’s MACD is 0.06, which suggests AVIR is a Sell.
        What is AVIR’s 5-day moving average?
        AVIR’s 5-day moving average is 3.89, which suggests AVIR is a Buy.
          What is AVIR’s 20-day moving average?
          AVIR 20-day moving average is 3.79, which suggests AVIR is a Buy.
            What is AVIR’s 50-day moving average?
            AVIR’s 50-day moving average is 3.69, which suggests AVIR is a Buy.
              What is AVIR’s 200-day moving average?
              AVIR’s 200-day moving average is 3.69, which suggests AVIR is a Buy.
                What is AVIR’s Williams % R (14)?
                AVIR’s Williams % R (14) is -24.80, which suggests AVIR is a Buy.
                  What is AVIR’s CCI (14)?
                  AVIR’s CCI (14) is 139.83, which suggests AVIR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis